20 LATEST RESOURCES (66 INDEXED)
Monoamine Oxidase Inhibitors for Trichotillomania: A Case Series · March 2023
Abstracts
Journal of Clinical Psychopharmacology
The Prescriber’s Guide to Classic MAO Inhibitors (Phenelzine, Tranylcypromine, Isocarboxazid) for Treatment-Resistant Depression · July 2022
Articles
CNS Spectrums
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study · July 2021
Articles
CNS Drugs
Time to Reconsider Monoamine Oxidase Inhibitors for Obsessive Compulsive Disorder?: A Case Series Using Phenelzine · July 2021
Abstracts
Journal of Clinical Psychopharmacology
Selegiline Reduces Daytime Sleepiness in Patients with Parkinson’s Disease · March 2021
Articles
Brain and Behavior
A Comparative Study of Fluoxetine, Moclobemide, and Tianeptine in the Treatment of Posttraumatic Stress Disorder Following an Earthquake · April 2020
Abstracts
European Psychiatry
Phase 2 Trial of Monoamine Oxidase Inhibitor Phenelzine in Biochemical Recurrent Prostate Cancer · March 2020
Articles (Manuscripts-Versions)
PubMed Central>Prostate Cancer and Prostatic Diseases
Rapid and Sustained Improvement in Treatment-Refractory Depression through Use of Acute Intravenous Ketamine and Concurrent Transdermal Selegiline: A Case Series · October 2019
Abstracts
Journal of Affective Disorders
Selegiline: A Molecule with Innovative Potential · September 2019
Articles
Journal of Neural Transmission
Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease · July 2019
Abstracts
Clinical Neuropharmacology
Comparison of Selegiline and Levodopa Combination Therapy versus Levodopa Monotherapy in the Treatment of Parkinson’s Disease: A Meta-Analysis · June 2019
Abstracts
Aging Clinical and Experimental Research
Interaction between Monoamine Oxidase B Inhibitors and Selective Serotonin Reuptake Inhibitors · June 2018
Articles
NCBI>Canadian Journal of Hospital Pharmacy
Long-Term Monitoring Gait Analysis Using a Wearable Device in Daily Lives of Patients with Parkinson’s Disease: The Efficacy of Selegiline Hydrochloride for Gait Disturbance · October 2017
Articles
Frontiers in Neurology
A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease · September 2017
Articles
Clinical Neuropharmacology
Efficacy of Rasagiline and Selegiline in Parkinson’s Disease: A Head-to-Head 3-Year Retrospective Case-Control Study · May 2017
Articles
Journal of Neurology
Efficacy of Rasagiline and Selegiline in Parkinson’s Disease: A Head-to-Head 3-Year Retrospective Case-Control Study · May 2017
Articles
Journal of Neurology
Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study · September 2016
Articles
Clinical Neuropharmacology
Treatment of Mild Camptocormia with Selegiline in Patients with Parkinson’s Disease · June 2016
Abstracts
European Neurology
Critical Appraisal of Selegiline Transdermal System for Major Depressive Disorder · February 2016
Abstracts
Expert Opinion on Drug Delivery
Moclobemide as Add-On Therapy to Agomelatine in a Patient with Treatment-Resistant Major Depressive Disorder: A Psychopharmacological Case · September 2015
Abstracts
Wiener Klinische Wochenschrift